These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21225232)

  • 1. A haplotype of TGFBR1 is predominantly found in non-small cell lung cancer patients displaying TGFBR1 allelic-specific expression.
    Sun J; Lei Z; Liu RY; Lu Y; Zhuang Z; Jiang X; Qian Q; Liu Z; Zhao J; Zhang HT
    Oncol Rep; 2011 Mar; 25(3):685-91. PubMed ID: 21225232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFBR1 haplotypes and risk of non-small-cell lung cancer.
    Lei Z; Liu RY; Zhao J; Liu Z; Jiang X; You W; Chen XF; Liu X; Zhang K; Pasche B; Zhang HT
    Cancer Res; 2009 Sep; 69(17):7046-52. PubMed ID: 19690145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
    Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
    Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
    Lou Y; Fang CQ; Li JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
    Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
    Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
    Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
    BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.
    Pasche B; Wisinski KB; Sadim M; Kaklamani V; Pennison MJ; Zeng Q; Bellam N; Zimmerman J; Yi N; Zhang K; Baron J; Stram DO; Hayes MG
    J Exp Clin Cancer Res; 2010 May; 29(1):57. PubMed ID: 20500843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
    Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer.
    Jaffrey RG; Pritchard SC; Clark C; Murray GI; Cassidy J; Kerr KM; Nicolson MC; McLeod HL
    Cancer Res; 2000 Aug; 60(16):4349-52. PubMed ID: 10969775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
    Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
    J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer.
    Martinez-Canto A; Castillejo A; Mata-Balaguer T; Castillejo MI; Hernandez-Illan E; Irles E; Barbera VM; Egoavil C; Guarinos C; Alenda C; Ochoa E; Lazaro R; Fajardo S; Lacueva J; Calpena R; Soto JL
    PLoS One; 2012; 7(1):e30812. PubMed ID: 22292045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
    Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel microdeletion in the transforming growth factor beta type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma.
    Wang JC; Su CC; Xu JB; Chen LZ; Hu XH; Wang GY; Bao Y; Huang Q; Fu SB; Li P; Lu CQ; Zhang RM; Luo ZW
    Genes Chromosomes Cancer; 2007 Feb; 46(2):192-201. PubMed ID: 17117417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.
    Ythier D; Brambilla E; Binet R; Nissou D; Vesin A; de Fraipont F; Moro-Sibilot D; Lantuejoul S; Brambilla C; Gazzeri S; Pedeux R
    Lung Cancer; 2010 Aug; 69(2):180-6. PubMed ID: 19962781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.